Table 2. Mean changes of primary outcomes between groups from baseline to final follow-up.
| Group A (hyaluronic acid) | Group B (verapamil) | p-value | |
|---|---|---|---|
| Plaque size (mm)a | -1.50 (1.60.2.10) | -1.20 (0.80.1.30) | 0.1 |
| Penile curvature (°)a | -9.50 (4.50.13.00) | -4.50 (2.50.7.50) | <0.01 |
| IIEF-15 scoreb | 1.0 (1.12.1.94) | 0.0 (-0.04.0.14) | <0.05 |
| VAS scoreb | - 4.0 (-4.11.-3.65) | -1.0 (-0.50.2.01) | <0.05 |
IIEF: International Index of Erectile Function, VAS: visual analogue scale.
aValues are presented as median (interquartile range). bValues are presented as median (95% confidence interval).